Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
2021
2020
2019
Profitability Metrics
Gross Margin
11.30%
Operating Margin
2.28%
Net Margin
1.24%
Efficiency Metrics
Revenue per Expense Ratio
1.02
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
4.86%
Income Tax Rate
50.57%
EPS
0.9900000000
Balance Sheet Analysis
Current Ratio
1.60
Cash Ratio
0.44
Working Capital
$613.57M
Debt to Equity
0.75
Debt to Assets
26.13%
Equity Ratio
34.74%
Cash Flow Analysis
Operating Cash Flow Ratio
5.24%
Free Cash Flow Ratio
1.23%
CapEx to Revenue
4.00%
Dividends Paid
$22.81M
Stock Buybacks
$4.12M
Total Shareholder Returns
$26.93M
Cash Position Change
42.07%
Detailed Growth Metrics
Core Performance
Revenue
6.30%
Net Income
-47.66%
EPS
-47.06%
Operating Income
-6.23%
Operational Efficiency
R&D Expenses
0.00%
SG&A Expenses
8.02%
Operating Cash Flow
230.13%
Free Cash Flow
165.68%
Balance Sheet Health
Assets
29.78%
Debt
129.32%
Book Value per Share
5.68%
Inventory
19.69%
Shareholder Returns
Dividends per Share
-0.62%
Shares Outstanding
-1.36%
Long Term Trends
3Y Revenue/Share
2.40%
5Y Revenue/Share
4.99%
3Y Dividend/Share
0.00%
5Y Dividend/Share
1.00%